Skip to main content
Clinical Trials/DRKS00010927
DRKS00010927
Completed
Not Applicable

Cholinergic network modulation in disinhibited eating behaviour - IFB-FluPET/MR

niversitätsklinikum Leipzig AöRKlinik und Poliklinik für Nuklearmedizin0 sites37 target enrollmentAugust 4, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
disinhibited eating behaviour
Sponsor
niversitätsklinikum Leipzig AöRKlinik und Poliklinik für Nuklearmedizin
Enrollment
37
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 4, 2016
End Date
February 8, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Leipzig AöRKlinik und Poliklinik für Nuklearmedizin

Eligibility Criteria

Inclusion Criteria

  • obese: BMI \> 35 kg/m²; healthy control: BMI \< 25 kg/m2
  • \- age between 18\-65 years; ? / ?
  • \- non\-smoking

Exclusion Criteria

  • \- current or past neurological or psychiatric disease, (i.e. depression and anxiety)
  • \- neurosurgical interventions
  • \- structural tissue lesions in the braín (e.g. stroke, trauma)
  • \- use of anorexic medication or other interventions for weight loss in the past 6 months
  • \- prescription medication (i.e. neurotropic drugs);
  • \- past or present history of alcohol misuse or the use of illegal drugs (ensured by means of psychological tests and urine Screening)
  • \- known cognitive deficits or speech impairment
  • \- simultaneous participation in any other interventional clinical study according to the German Medicinal Products Act (MPA)
  • \- pregnancy and breast\-feeding (or other contraindications for the use of radiotracers)
  • \- MRI contraindications such as ferro\-magnetism, or claustrophobia

Outcomes

Primary Outcomes

Not specified

Similar Trials